HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kolbert, K. S. Articles by Sgouros, G. Search for Related Content PubMed PubMed Citation Articles by Kolbert, K. S. Articles by Sgouros, G.

Murine S Factors for Liver, Spleen, and Kidney

¹ Imaging and Spectroscopic Physics Service, Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York

Preclinical evaluation of new radiopharmaceuticals is performed in animal systems before testing is started in humans. These studies, often performed in murine or other rodent models, are important in understanding the relationship between absorbed dose and response, which can be translated to preclinical results for humans. In performing such calculations, either electrons are assumed to deposit all of their energy locally or idealized models of mouse anatomy are used to determine absorbed fractions. Photon contributions are generally considered negligible. To improve the accuracy of such absorbed dose calculations, mouse-specific S factors for ¹³¹I, ¹⁵³Sm, ³²P, ¹⁸⁸Re, and ⁹⁰Y have been generated, and the photon and electron portions have been tabulated separately. Absorbed fractions for 5 monoenergetic electrons, ranging in energy from 0.5 to 2 MeV, are also provided. Methods: Female athymic mouse MR images were obtained on a 4.7-T MRI device. Fifteen T1-weighted, 1.5-mm-thick slices (0.5-mm gap) were collected. Using a previously developed software package, 3-dimensional Internal Dosimetry (3D-ID), organ contours were drawn to obtain a 3-dimensional representation of liver, kidneys, and spleen. Using a point-kernel convolution, the mean absorbed dose to each organ from the individual contributions of each source organ were calculated. S factor equivalent values were obtained by assuming a uniform distribution of radioactivity in each organ. Results were validated by comparing 3D-ID generated electron S factors for different-sized spheres with published data. Depending on matrix size, sphere size, and radionuclide, 1% (256² matrix) to 18% (64² matrix) agreement was obtained. Results: S factor values were calculated for liver, spleen, and right and left kidneys. Cross-organ electron-absorbed fractions of up to 0.33 were obtained (e.g., ⁹⁰Y right kidney to liver). Comparisons between S factor values and values obtained assuming complete absorption of electron energy yielded differences of more than 190% (⁹⁰Y spleen self-dose). Conclusion: The effect of cross-organ and self-absorbed dose is dependent on emission energy and organ geometry and should be considered in murine dose estimates. The approach used to generate these S factors is applicable to other animal systems and also to nonuniform activity distributions that may be obtained by small-animal SPECT or PET imaging or by quantitative autoradiography.

Key Words: S factors • murine model • dosimetry • ⁹⁰Y • ¹³¹I • ¹⁵³Sm • ³²P • ¹⁸⁸Re • monoenergetic electron

This article has been cited by other articles:

				M. A. Keenan, M. G. Stabin, W. P. Segars, and M. J. Fernald RADAR Realistic Animal Model Series for Dose Assessment J. Nucl. Med., March 1, 2010; 51(3): 471 - 476. [Abstract] [Full Text] [PDF]

				M. G. Stabin, T. E. Peterson, G. E. Holburn, and M. A. Emmons Voxel-Based Mouse and Rat Models for Internal Dose Calculations J. Nucl. Med., April 1, 2006; 47(4): 655 - 659. [Abstract] [Full Text] [PDF]

				D. Berndorff, S. Borkowski, S. Sieger, A. Rother, M. Friebe, F. Viti, C. S. Hilger, J. E. Cyr, and L. M. Dinkelborg Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate Clin. Cancer Res., October 1, 2005; 11(19): 7053s - 7063s. [Abstract] [Full Text] [PDF]

				C. Hindorf, M. Ljungberg, and S.-E. Strand Evaluation of Parameters Influencing S Values in Mouse Dosimetry J. Nucl. Med., November 1, 2004; 45(11): 1960 - 1965. [Abstract] [Full Text] [PDF]

				M. W. Konijnenberg, M. Bijster, E. P. Krenning, and M. de Jong A Stylized Computational Model of the Rat for Organ Dosimetry in Support of Preclinical Evaluations of Peptide Receptor Radionuclide Therapy with 90Y, 111In, or 177Lu J. Nucl. Med., July 1, 2004; 45(7): 1260 - 1269. [Abstract] [Full Text] [PDF]

				N.-K. V. Cheung, S. Modak, Y. Lin, H. Guo, P. Zanzonico, J. Chung, Y. Zuo, J. Sanderson, S. Wilbert, L. J. Theodore, et al. Single-Chain Fv-Streptavidin Substantially Improved Therapeutic Index in Multistep Targeting Directed at Disialoganglioside GD2 J. Nucl. Med., May 1, 2004; 45(5): 867 - 877. [Abstract] [Full Text] [PDF]

				S. Palm, R. M. Enmon Jr., C. Matei, K. S. Kolbert, S. Xu, P. B. Zanzonico, R. L. Finn, J. A. Koutcher, S. M. Larson, and G. Sgouros Pharmacokinetics and Biodistribution of 86Y-Trastuzumab for 90Y Dosimetry in an Ovarian Carcinoma Model: Correlative MicroPET and MRI J. Nucl. Med., July 1, 2003; 44(7): 1148 - 1155. [Abstract] [Full Text] [PDF]